BOLD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Boundless Bio Inc (BOLD) is not a strong buy for a beginner, long-term investor at this time. While the technical indicators show bullish momentum, the company's financial performance is weak, with significant losses in net income and EPS. Additionally, there are no positive catalysts, news, or trading signals to support an immediate investment. The stock's overbought RSI and lack of significant trading trends further suggest caution.
The MACD is positive and expanding, indicating bullish momentum. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the RSI is at 90.92, signaling the stock is overbought. Key resistance levels are at 1.578 and 1.722, with support at 1.112 and 0.968.
NULL identified. No recent news or significant trading trends.
Weak financial performance with declining net income (-21.66% YoY) and EPS (-95.87% YoY). The RSI indicates an overbought condition, suggesting potential for a short-term pullback.
In Q4 2025, the company reported zero revenue growth (0.00% YoY). Net income dropped to -$12.88M (-21.66% YoY), and EPS fell to -0.58 (-95.87% YoY). Gross margin remains at 0.
No analyst ratings or price target changes available.
